A detailed history of Kazazian Asset Management, LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 2,660 shares of ACLX stock, worth $191,067. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,660
Holding current value
$191,067
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$75.39 - $106.53 $200,537 - $283,369
2,660 New
2,660 $204 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.15B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Kazazian Asset Management, LLC Portfolio

Follow Kazazian Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kazazian Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kazazian Asset Management, LLC with notifications on news.